Polyomavirus Infections - 25 Studies Found
Recruiting |
: Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With 3 mg/kg BW Ipilimumab (Yervoy®) Versus Observation : Merkel Cell Carcinoma : 2014-06-20 : Drug: Ipilimumab adjuvant treatment of completely resected Merkel cell carcinoma |
Recruiting |
: Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200) : Carcinoma, Merkel Cell : 2014-06-02 : Drug: Avelumab Avelumab will be administered at a dose of 10 milligram per kilogram (mg/kg) as 1-hour in |
Recruiting |
: F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2014-01-31 :
|
Active, not recruiting |
: A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2014-01-10 : Biological: GLA-SE Glucopyranosyl Lipid A in Stable Emulsion |
Withdrawn |
: Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2013-07-28 : Drug: Ipilimumab Ipilimumab is a recombinant, human monoclonal antibody that binds to CTLA-4. It is comm |
Terminated |
: Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma :
: 2012-12-27 :
|
Completed |
: IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer : Merkel Cell Carcinoma : 2011-09-23 :
|
Active, not recruiting |
: Merkel Positron Emission Tomography (PET) Protocol : Merkel Cell Carcinoma : 2009-11-12 :
|
Recruiting |
: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma :
: 2017-03-01 :
|
Active, not recruiting |
: Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma :
: 2013-12-19 : Drug: Cabozantinib Cabozantinib 60 mg Oral Daily 28 days (4 weeks) |